Literature DB >> 17957142

Modulation of the p53-MDM2 interaction by phosphorylation of Thr18: a computational study.

Hui Jun Lee1, Deepa Srinivasan, David Coomber, David P Lane, Chandra S Verma.   

Abstract

The transcription factor p53 is under negative regulation by the ubiquitin ligase MDM2 and its close homologue MDM4. In the bound complex between MDM2 and p53, the transactivation domain of p53 adopts an amphipathic helical conformation which optimizes the spatial organization of three key hydrophobic residues (Phe19, Trp23, Leu26) for maximum interactions. The interaction with MDM2 is known to be abrogated by phosphorylation of Ser/Thr residues in the MDM2 N-terminal domain and in the p53 transactivation domain. In the latter, phosphorylation of Thr18 has been attributed to destabilize a key hbond between Thr18 and Asp21. This interaction has been thought to be critical for the formation of the helical conformation of the p53 transactivation domain. Molecular dynamics simulations of the p53 transactivation domain suggest that phosphorylation of either Thr18 or Ser20 does not disrupt its helical structure but does result in reduced affinities for MDM2. While interactions between the Thr18 and Asp21 are indeed broken due to charge-charge repulsions, the peptide has enough inherent flexibility to form alternate patterns of hbonds, resulting in the maintenance of helicity. Electrostatics of MDM2 reveal local anionic patches in the region where Thr18 docks. These suggest that repulsions will arise because the MDM2 surface will force the p53 to bind in a manner that will place the negatively charged phosphorylated Thr18 near this anionic region. A similar, albeit somewhat attenuated pattern of electrostatic modulations, is seen for a model of MDM4 that has been built. Mutants of MDM2 and MDM4 have been designed to attenuate this anionicity and have been computationally demonstrated to enhance the binding of the phosphorylated peptides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957142     DOI: 10.4161/cc.6.21.4923

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  20 in total

1.  Effects of phosphorylation on the intrinsic propensity of backbone conformations of serine/threonine.

Authors:  Erbin He; Guanghui Yan; Jian Zhang; Jun Wang; Wenfei Li
Journal:  J Biol Phys       Date:  2016-01-12       Impact factor: 1.365

Review 2.  Molecular simulations of protein dynamics: new windows on mechanisms in biology.

Authors:  Guy G Dodson; David P Lane; Chandra S Verma
Journal:  EMBO Rep       Date:  2008-02       Impact factor: 8.807

Review 3.  Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs).

Authors:  Francois-Xavier Theillet; Andres Binolfi; Tamara Frembgen-Kesner; Karan Hingorani; Mohona Sarkar; Ciara Kyne; Conggang Li; Peter B Crowley; Lila Gierasch; Gary J Pielak; Adrian H Elcock; Anne Gershenson; Philipp Selenko
Journal:  Chem Rev       Date:  2014-06-05       Impact factor: 60.622

4.  A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2.

Authors:  Karim M ElSawy; Adelene Sim; David P Lane; Chandra S Verma; Leo Sd Caves
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  p53 N-terminal phosphorylation: a defining layer of complex regulation.

Authors:  Lisa M Miller Jenkins; Stewart R Durell; Sharlyn J Mazur; Ettore Appella
Journal:  Carcinogenesis       Date:  2012-04-12       Impact factor: 4.944

6.  Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.

Authors:  Chong Li; Marzena Pazgier; Changqing Li; Weirong Yuan; Min Liu; Gang Wei; Wei-Yue Lu; Wuyuan Lu
Journal:  J Mol Biol       Date:  2010-03-10       Impact factor: 5.469

7.  On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: a Brownian dynamics study.

Authors:  Karim M ElSawy; Chandra S Verma; Thomas L Joseph; David P Lane; Reidun Twarock; Leo S D Caves
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

8.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

Authors:  Hanqiao Feng; Lisa M Miller Jenkins; Stewart R Durell; Ryo Hayashi; Sharlyn J Mazur; Scott Cherry; Joseph E Tropea; Maria Miller; Alexander Wlodawer; Ettore Appella; Yawen Bai
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

9.  Differences in the transactivation domains of p53 family members: a computational study.

Authors:  Jagadeesh N Mavinahalli; Arumugam Madhumalar; Roger W Beuerman; David P Lane; Chandra Verma
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

Review 10.  Targeting prostate cancer based on signal transduction and cell cycle pathways.

Authors:  John T Lee; Brian D Lehmann; David M Terrian; William H Chappell; Franca Stivala; Massimo Libra; Alberto M Martelli; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.